Epigenetic Regulation of Vascular Diseases

Abdalrahman Zarzour, Ha Won Kim, Neal Lee Weintraub

Research output: Contribution to journalArticle

Abstract

Epigenetic regulatory mechanisms, encompassing diverse molecular processes including DNA methylation, histone post-Translational modifications, and noncoding RNAs, are essential to numerous processes such as cell differentiation, growth and development, environmental adaptation, aging, and disease states. In many cases, epigenetic changes occur in response to environmental cues and lifestyle factors, resulting in persistent changes in gene expression that affect vascular disease risk during the lifetime of the individual. Biological aging-a powerful cardiovascular risk factor-is partly genetically determined yet strongly influenced by traditional risk factors, reflecting epigenetic modulation. Quantification of specific DNA methylation patterns may serve as an accurate predictor of biological age-a concept known as the epigenetic clock, which could help to refine cardiovascular risk assessment. Epigenetic reprogramming of monocytes rewires cellular immune signaling and induces a metabolic shift toward aerobic glycolysis, thereby increasing innate immune responses. This form of trained epigenetic memory can be maladaptive, thus augmenting vascular inflammation. Somatic mutations in epigenetic regulatory enzymes lead to clonal hematopoiesis of indeterminate potential, a precursor of hematologic malignancies and a recently recognized cardiovascular risk factor; moreover, epigenetic regulators are increasingly being targeted in cancer therapeutics. Thus, understanding epigenetic regulatory mechanisms lies at the intersection between cancer and cardiovascular disease and is of paramount importance to the burgeoning field of cardio-oncology (Graphic Abstract).

Original languageEnglish (US)
Pages (from-to)984-990
Number of pages7
JournalArteriosclerosis, thrombosis, and vascular biology
Volume39
Issue number6
DOIs
StatePublished - Jun 1 2019

Fingerprint

Vascular Diseases
Epigenomics
DNA Methylation
Untranslated RNA
Hematopoiesis
Glycolysis
Hematologic Neoplasms
Post Translational Protein Processing
Growth and Development
Innate Immunity
Histones
Cues
Blood Vessels
Life Style
Monocytes
Cell Differentiation
Neoplasms
Cardiovascular Diseases
Inflammation
Gene Expression

Keywords

  • environmental cues
  • epigenomics
  • histones
  • risk factors
  • vascular diseases

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Epigenetic Regulation of Vascular Diseases. / Zarzour, Abdalrahman; Kim, Ha Won; Weintraub, Neal Lee.

In: Arteriosclerosis, thrombosis, and vascular biology, Vol. 39, No. 6, 01.06.2019, p. 984-990.

Research output: Contribution to journalArticle

@article{3324de3a88df485b9c923ebfb9f3aec1,
title = "Epigenetic Regulation of Vascular Diseases",
abstract = "Epigenetic regulatory mechanisms, encompassing diverse molecular processes including DNA methylation, histone post-Translational modifications, and noncoding RNAs, are essential to numerous processes such as cell differentiation, growth and development, environmental adaptation, aging, and disease states. In many cases, epigenetic changes occur in response to environmental cues and lifestyle factors, resulting in persistent changes in gene expression that affect vascular disease risk during the lifetime of the individual. Biological aging-a powerful cardiovascular risk factor-is partly genetically determined yet strongly influenced by traditional risk factors, reflecting epigenetic modulation. Quantification of specific DNA methylation patterns may serve as an accurate predictor of biological age-a concept known as the epigenetic clock, which could help to refine cardiovascular risk assessment. Epigenetic reprogramming of monocytes rewires cellular immune signaling and induces a metabolic shift toward aerobic glycolysis, thereby increasing innate immune responses. This form of trained epigenetic memory can be maladaptive, thus augmenting vascular inflammation. Somatic mutations in epigenetic regulatory enzymes lead to clonal hematopoiesis of indeterminate potential, a precursor of hematologic malignancies and a recently recognized cardiovascular risk factor; moreover, epigenetic regulators are increasingly being targeted in cancer therapeutics. Thus, understanding epigenetic regulatory mechanisms lies at the intersection between cancer and cardiovascular disease and is of paramount importance to the burgeoning field of cardio-oncology (Graphic Abstract).",
keywords = "environmental cues, epigenomics, histones, risk factors, vascular diseases",
author = "Abdalrahman Zarzour and Kim, {Ha Won} and Weintraub, {Neal Lee}",
year = "2019",
month = "6",
day = "1",
doi = "10.1161/ATVBAHA.119.312193",
language = "English (US)",
volume = "39",
pages = "984--990",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Epigenetic Regulation of Vascular Diseases

AU - Zarzour, Abdalrahman

AU - Kim, Ha Won

AU - Weintraub, Neal Lee

PY - 2019/6/1

Y1 - 2019/6/1

N2 - Epigenetic regulatory mechanisms, encompassing diverse molecular processes including DNA methylation, histone post-Translational modifications, and noncoding RNAs, are essential to numerous processes such as cell differentiation, growth and development, environmental adaptation, aging, and disease states. In many cases, epigenetic changes occur in response to environmental cues and lifestyle factors, resulting in persistent changes in gene expression that affect vascular disease risk during the lifetime of the individual. Biological aging-a powerful cardiovascular risk factor-is partly genetically determined yet strongly influenced by traditional risk factors, reflecting epigenetic modulation. Quantification of specific DNA methylation patterns may serve as an accurate predictor of biological age-a concept known as the epigenetic clock, which could help to refine cardiovascular risk assessment. Epigenetic reprogramming of monocytes rewires cellular immune signaling and induces a metabolic shift toward aerobic glycolysis, thereby increasing innate immune responses. This form of trained epigenetic memory can be maladaptive, thus augmenting vascular inflammation. Somatic mutations in epigenetic regulatory enzymes lead to clonal hematopoiesis of indeterminate potential, a precursor of hematologic malignancies and a recently recognized cardiovascular risk factor; moreover, epigenetic regulators are increasingly being targeted in cancer therapeutics. Thus, understanding epigenetic regulatory mechanisms lies at the intersection between cancer and cardiovascular disease and is of paramount importance to the burgeoning field of cardio-oncology (Graphic Abstract).

AB - Epigenetic regulatory mechanisms, encompassing diverse molecular processes including DNA methylation, histone post-Translational modifications, and noncoding RNAs, are essential to numerous processes such as cell differentiation, growth and development, environmental adaptation, aging, and disease states. In many cases, epigenetic changes occur in response to environmental cues and lifestyle factors, resulting in persistent changes in gene expression that affect vascular disease risk during the lifetime of the individual. Biological aging-a powerful cardiovascular risk factor-is partly genetically determined yet strongly influenced by traditional risk factors, reflecting epigenetic modulation. Quantification of specific DNA methylation patterns may serve as an accurate predictor of biological age-a concept known as the epigenetic clock, which could help to refine cardiovascular risk assessment. Epigenetic reprogramming of monocytes rewires cellular immune signaling and induces a metabolic shift toward aerobic glycolysis, thereby increasing innate immune responses. This form of trained epigenetic memory can be maladaptive, thus augmenting vascular inflammation. Somatic mutations in epigenetic regulatory enzymes lead to clonal hematopoiesis of indeterminate potential, a precursor of hematologic malignancies and a recently recognized cardiovascular risk factor; moreover, epigenetic regulators are increasingly being targeted in cancer therapeutics. Thus, understanding epigenetic regulatory mechanisms lies at the intersection between cancer and cardiovascular disease and is of paramount importance to the burgeoning field of cardio-oncology (Graphic Abstract).

KW - environmental cues

KW - epigenomics

KW - histones

KW - risk factors

KW - vascular diseases

UR - http://www.scopus.com/inward/record.url?scp=85066511450&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066511450&partnerID=8YFLogxK

U2 - 10.1161/ATVBAHA.119.312193

DO - 10.1161/ATVBAHA.119.312193

M3 - Article

C2 - 31070469

AN - SCOPUS:85066511450

VL - 39

SP - 984

EP - 990

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 6

ER -